https://doi.org/10.1093/annonc/mdw067
M
Mahasti Saghatchian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
99
Papers
1.6K
Citations
18
h-index
26
i10-index
Mahasti Saghatchian is an academic researcher from Hôpital américain de paris. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies. The author has an h-index of 18, co-authored 85 publications.
ORCID: 0000-0003-4628-7783Papers by this author
worksA phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
2016 · Annals of Oncology · 278 citations
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
2021 · Annals of Oncology · 119 citations
https://doi.org/10.1016/j.annonc.2021.04.011
Serum HER-2 extracellular domain: Relationship with clinicobiological presentation and prognostic value before and after primary treatment in 701 breast cancer patients
2004 · The International Journal of Biological Markers · 32 citations
https://doi.org/10.5301/jbm.2008.1233
Trastuzumab deruxtecan in previously treated <scp>HER2</scp>‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France
2024 · Cancer Medicine · 14 citations
https://doi.org/10.1002/cam4.7168
Identifying potential indicators to measure the outcome of translational cancer research: a mixed methods approach
2015 · Health Research Policy and Systems · 4 citations
https://doi.org/10.1186/s12961-015-0060-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat